Our results indicated that nApoE41-151 does regulate the expression of several genes including a novel, previously uncharacterized gene, CXorf56. These findings have potential broad implications implicating apoE4 to dementia risk perhaps through microglia activation and enhanced inflammation in the AD brain. Here, STEEP1 is linked to Alzheimer disease.